相关实验视频
Updated: Jun 30, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
表皮-介质细胞过渡和免疫疗法之间的双向交叉:一个文献计量研究
Wei Du1, Zemin Tang1, Ashuai Du2,3
1Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, China.
Human vaccines & immunotherapeutics
|March 19, 2024
概括
本文献分析揭示了表皮-介质酶转换 (EMT) 和免疫治疗的研究趋势. 新兴的关键词,如"免疫透"和"ferroptosis"突出提高免疫疗法策略的新途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物医学研究生物医学研究
背景情况:
- 免疫疗法在癌症治疗方面获得了显著的关注.
- 表皮-介质细胞过渡 (EMT) 和免疫疗法之间的相互作用是研究的一个关键领域.
- 目前缺乏对EMT和免疫疗法的研究趋势的全面分析.
研究的目的:
- 提供EMT-免疫疗法研究进展的文献统计概述.
- 识别关键趋势,有影响力的国家和该领域的领先期刊.
- 突出新兴的关键词和潜在的未来研究方向.
主要方法:
- 从科学网络核心集合 (WOSCC) 获取的1302篇文章的图书统计分析.
- 分析出版量,引用和关键词趋势的分析.
- 确定EMT-免疫疗法研究领域的领先国家和期刊.
主要成果:
- 在研究量方面,中国领先 (49.07%),其次是美国 (16.89%).
- 根据引用和爆发性,美国显示了最高的影响力.
- 免疫疗法的边界是最有影响力的期刊.
- "免疫透"",生物信息学分析"",传统中医"",基因签名"和"铁"是新兴的关键词.
结论:
- 图书统计分析提供了对EMT-免疫疗法研究领域的洞察.
- 新兴的关键词为了解EMT和免疫治疗的联合作用提供了新的方向.
- 这项研究可以指导提高免疫疗法疗效的策略.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K

